Abbott Laboratories

Pharmaceuticals
United States
2016 Revenue (US$ Millions)$20,853
Revenue Growth (%)2.20%
Net Income (US$ Millions)$1,400
Earnings Per Share (US$)$0.94
EPS Growth Rate (%)-67.81%
Profit Margin6.71%
Total Equity (US$ Millions)$20,538
Return on Equity (%)6.60%
Long Term Debt (US$ Millions)$20,681
Debt To Equity Ratio (%)1.01%
Total Assets (US$ Millions)$52,666
Current Assets (US$ Millions)$26,776
Current Liabilities (US$ Millions)$6,660
Cost of Goods Sold (US$ Millions)$9,024
Inventory Turnover3.59